Studies using gamma scintigraphy after inhalation of technetium-99m-labeled sulfur colloid particles have shown that ivacaftor therapy in CF patients with the G551D-CFTR mutation improves mucociliary clearance (MCC) which correlates with improved lung function. Here, CFTR is linked to cystic fibrosis.